PT Tempo Scan Pacific Tbk (TSPC.JK)
- Previous Close
2,580.00 - Open
2,580.00 - Bid 2,610.00 x --
- Ask 2,620.00 x --
- Day's Range
2,570.00 - 2,620.00 - 52 Week Range
1,915.00 - 2,900.00 - Volume
440,700 - Avg. Volume
1,593,707 - Market Cap (intraday)
11.771T - Beta (5Y Monthly) 0.28
- PE Ratio (TTM)
8.13 - EPS (TTM)
320.95 - Earnings Date Apr 30, 2025
- Forward Dividend & Yield 100.00 (3.88%)
- Ex-Dividend Date Dec 3, 2024
- 1y Target Est
--
PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. The company operates through Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services segments. It is involved in the pharmaceutical and medical devices trading; manufacture of soaps, herbal products, powder milk, food and beverages, and plastic packaging; and manufacturing and trading of consumer products, cosmetics, and household products. The company sells its products under the Bodrex, Oskadon, Neo rheumacyl, Bodrexin, Contrexyn, Contrex, Oskadryl, Vidoran, Neodulax, Vidoran, Hemaviton, Neo Hormoviton, Polaris, Vitonal, Vitamin IPI, Neo rheumacyl Herbal, Wybert Herbal, Bodrexin Herbal, Herbalax, Marina, Natural Honey, Claudia, Total Care, and ULTIMA II brands. It also engages in the construction and rental of buildings; provision of warehousing, advertising and promotion, research and development, and information technology and communication network systems services; and procurement, distribution, and marketing activities. The company was formerly known as PT Scanchemie. PT Tempo Scan Pacific Tbk was founded in 1970 and is based in Jakarta, Indonesia. The company operates as a subsidiary of PT Bogamulia Nagadi.
www.temposcangroup.com4,460
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: TSPC.JK
View MorePerformance Overview: TSPC.JK
Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is IDX COMPOSITE (^JKSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TSPC.JK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TSPC.JK
View MoreValuation Measures
Market Cap
11.64T
Enterprise Value
7.91T
Trailing P/E
8.04
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.85
Price/Book (mrq)
1.34
Enterprise Value/Revenue
0.58
Enterprise Value/EBITDA
3.42
Financial Highlights
Profitability and Income Statement
Profit Margin
10.75%
Return on Assets (ttm)
8.69%
Return on Equity (ttm)
16.96%
Revenue (ttm)
13.49T
Net Income Avi to Common (ttm)
1.45T
Diluted EPS (ttm)
320.95
Balance Sheet and Cash Flow
Total Cash (mrq)
4.81T
Total Debt/Equity (mrq)
12.13%
Levered Free Cash Flow (ttm)
315.83B